PCE Stats & Data
Ci-400
Eticyclidine
Cyclohexamine
NPS DataHub
MW203.33
FormulaC14H21N
CAS2201-15-2
IUPACN-ethyl-1-phenylcyclohexylamine
SMILES
CCNC1(CCCCC1)c1ccccc1InChIKey
IFYLVUHLOOCYBG-UHFFFAOYSA-N
Psychoactive Class
Dissociative
Pharmacology
DrugBank
Half-life 96.0 hours
Absorption Bioavailability: 80%
Metabolism
Despite the low overall metabolism of tetrachloroethylene compared with other chlorinated solvents, its metabolism has been studied extensively in both human volunteers and laboratory animals, using both in vivo and in vitro techniques. The studies showed that many metabolites are produced, including some known to be cytotoxic, mutagenic or both. Tetrachloroethylene metabolism can be viewed as having three pathways. The first is cytochrome P-450-mediated (CYP-mediated) oxidation. The second and
Receptor Profile
Receptor Actions
Antagonists
NMDA receptor antagonist (noncompetitive)
Inhibitors
Dopamine-norepinephrine reuptake inhibitor
Serotonin reuptake inhibitor
Other
suspected μ-opioid receptor affinity
Effect Profile
Curated + 3 Reports
Dissociative
6.6
Strong dissociative depth, mania, motor impairment, and insight
Dissociative Depth×3
10
Mania / Compulsion×1
10
Insight / Novel Thought×2
8
Motor / Sensory Impairment×1
10
Based on reports from:
Duration Timeline
Bluelight
Onset
Comeup
Peak
Offset
After Effects
Oral
Total: 2-5 hours
Insufflated
Total: 2-5 hours
Smoked
Total: 2-5 hours
Community Effects
TripSit
Positive
dissociation
Tolerance & Pharmacokinetics
drugs.wikiTolerance Decay
Full tolerance
1d
Half tolerance
21d
Baseline
~28d
Experience Report Analysis
Erowid
3
Reports
3
With Age Data
5
Effects Detected
Demographics
Gender Distribution
Age Distribution
Effect Analysis
ErowidEffects aggregated from 3 experience reports (3 Erowid)
3
Reports
5
Effects Detected
2
Positive
1
Adverse
2
Neutral
Effect Sentiment Distribution
Confidence Distribution
Positive Effects 2
Empathy
100.0%
70%
Music Enhancement
100.0%
70%
Adverse Effects 1
Anxiety
100.0%
70%
Real-World Dose Distribution
62K DosesFrom 2 individual dose entries